Winning Points Advisors’s Biogen BIIB Stock Holding History

Winning Points Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,219	Closed	-$257K	–	54
2022 Q1	$257K	Sell	1,219 -300	-20%	-$65.2K	0.2%	51
2021 Q4	$355K	Buy	1,519 +300	+25%	+$77.1K	0.26%	53
2021 Q3	$345K	Hold	1,219	–	–	0.25%	51
2021 Q2	$422K	Hold	1,219	–	–	0.32%	44
2021 Q1	$341K	Hold	1,219	–	–	0.26%	52
2020 Q4	$298K	Hold	1,219	–	–	0.24%	51
2020 Q3	$346K	Hold	1,219	–	–	0.29%	42
2020 Q2	$326K	Hold	1,219	–	–	0.31%	39
2020 Q1	$386K	Sell	1,219 -300	-20%	-$91K	0.38%	42
2019 Q4	$451K	Hold	1,519	–	–	0.29%	52
2019 Q3	$350K	Hold	1,519	–	–	0.25%	54
2019 Q2	$355K	Hold	1,519	–	–	0.26%	53
2019 Q1	$359K	Hold	1,519	–	–	0.28%	53
2018 Q4	$463K	Buy	1,519 +100	+7%	+$31.9K	0.4%	45
2018 Q3	$501K	Sell	1,419 -100	-7%	-$34.4K	0.37%	49
2018 Q2	$441K	Hold	1,519	–	–	0.35%	49
2018 Q1	$403K	Hold	1,519	–	–	0.33%	53
2017 Q4	$484K	Hold	1,519	–	–	0.39%	46
2017 Q3	$476K	Hold	1,519	–	–	0.41%	48
2017 Q2	$413K	Hold	1,519	–	–	0.4%	47
2017 Q1	$414K	Buy	1,519 +35	+2%	+$9.9K	0.4%	48
2016 Q4	$421K	Buy	+1,484	New	+$440K	0.46%	46

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Winning Points Advisors's BIIB Position: Q2 2022 in Review

Winning Points Advisors sold out of Biogen (BIIB) in Q2 2022, closing a stake of 1,219 shares — an estimated $257K sold.

Winning Points Advisors first reported a position in BIIB in Q4 2016 and held it in 22 quarters. The position peaked at $501K in Q3 2018. 927 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.

Winning Points Advisors reported no remaining Biogen position as of Q2 2022 after selling out during the quarter.
Winning Points Advisors sold 1,219 Biogen shares in Q2 2022, an estimated $257K.
Winning Points Advisors first reported a position in Biogen in Q4 2016 and held it in 22 quarters.
Winning Points Advisors's Biogen position peaked at $501K in Q3 2018.
927 funds tracked by Wall St. Rank held Biogen as of Q2 2022.

Based on Winning Points Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.